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spread due to lymphatic blockage, in which case the establishment 
of the SLN concept seems to be not that easy [4, 5].
This paper is well organized only experimentally when it comes 
to the purpose of the study, but I doubt that this study contributes 
to the clinical usefulness of the SLN for rectal cancer treatment. 
We have different situations in rectal cancer that we should con-
sider. First, the concept of a sentinel lymph in rectal cancer is still 
uncertain. Skipped metastasis or aberrant metastasis because of 
lymphatic channel occlusion or other causes, such as associated 
inflammation, preoperative radiation, etc., have been noted. Even 
very low rectal cancer needing coloanal anastomosis can uncom-
monly spread into the inguinal basin [6]. Second, unfortunately, 
the outcome and influence of micrometastasis, as one of the aims 
of this study, have not been definitely established for cancer prog-
nosis in the node-negative group. We are still waiting for long-term 
outcomes. Third, even is sentinel LNs are identified and established, 
so far the treatment modality for rectal cancer has been already as 
surgery (total mesorectal excision or tumor related mesorectal ex-
cision), radiation and chemotherapy (FL) for both stage II and III 
cancers, and in my opinion, this treatment modality will not change 
until a newer, better treatment modality is identified or developed. 
Fourth, approximately 30% of rectal cancer patients have a posi-
tive regional LN at present, which means that the concept of a SLN 
is not meaningful in these patients. Thus, using the concept of the 
SLN might be time- and effort-consuming as a routine procedure, 
just showing the route of lymphatic drainage, and seems to have no 
clinical beneficial, except more careful check-ups for the patients 
with SLN micrometastasis in the node-negative group.
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